Theophylline and airway inflammation

Clinical and Experimental Allergy, Supplement

Volumn 28, Issue 3, 1998, Pages 35-41

  Rabe, K F ^a   Dent, G ^a  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADENOSINE; ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS; ASTHMA; BIOPSY; BRONCHI; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; EOSINOPHILS; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; THEOPHYLLINE;

EID: 0031879999     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Serafin WE. Drugs used in the treatment of asthma. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edition. New York: McGraw-Hill, 1996; 659-82.
2. Conti M, Nemoz G, Sette C, Vicini E. Recent-progress in understanding the hormonal regulation of phosphodiesterases. Endocrine Rev 1995; 16: 370-89.
3. Loughney K, Ferguson K. Identification and quantification of PDE isoenzymes and subtypes by molecular biological methods. In: Schudt C, Dent G and Rabe KF, eds. Phosphodiesterase Inhibitors. London: Academic Press, 1996; 1-19.
4. + T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Br J Pharmacol 1996; 118: 1945-58.
5. Dent G, Giembycz MA. Phosphodiesterase inhibitors: Lily the Pink's medicinal compound for asthma? Thorax 1996; 51: 647-9.
6. Dent G, Giembycz MA. Selective phosphodiesterase inhibitors in the therapy of asthma. Clin Immunother 1995; 3: 423-37.
7. de Boer J, Philpott AJ, van Amsterdam GM, Shahid M, Zaagsma J, Nicholson CD. Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors. Br J Pharmacol 1992; 106: 1028-34.
8. Rabe KF, Tenor H, Dent G, Schudt C, Liebig S, Magnussen H. Phosphodiesterase isoenzymes modulating inherent tone in human airways: identification and characterization. Am J Physiol 1993; 264 (Lung Cell Mol Physiol 8): L458-64.
9. Giembycz MA, Dent G, Souness JE. Theophylline and isoenzyme-selective phosphodiesterase inhibitors. In: Kay AB, ed. Allergy and Allergic Diseases. Oxford: Blackwell, 1997; 531-67.
10. Dent G, Rabe KF. Adenosine. In: Leff AR, ed. Pulmonary and Critical Care Pharmacology and Therapeutics. New York: McGraw-Hill, 1996; 173-80.
11. Church MK, Featherstone RL, Cushley MJ, Mann JS, Holgate ST. Relationships between adenosine, cyclic nucleotides, and xanthines in asthma. J Allergy Clin Immunol 1986; 78: 670-5.
12. Linden J. Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 1994; 15: 298-306.
13. 3 adenosine receptor. Proc Natl Acad Sci USA 1993; 90: 10365-9.
14. Joad JP, Kott KS. Effect of adenosine receptor ligands on cAMP content in human airways and peripheral lung. Am J Respir Cell Mol Biol 1993; 9: 134-40.
15. Bergstrand H. Phosphodiesterase inhibition and theophylline. Eur J Respir Dis 1980; 61 (Suppl. 109): 37-44.
16. 3 receptor expression and function in eosinophils. Am J Respir Cell Mol Biol 1997; 16: 531-7.
17. Yukawa T, Kroegel C, Chanez P et al. Effect of theophylline and adenosine on eosinophil function. Am Rev Respir Dis 1989; 140: 327-33.
18. Ward AJM, McKenniff M, Evans JM, Page CP, Costello JF. Theophylline - an immunomodulatory role in asthma? Am Rev Respir Dis 1993; 147: 518-23.
19. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Antiinflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994; 343: 1006-8.
20. Kidney JC, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ. Immunomodulation by theophylline in asthma: demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995; 151: 1907-14.
21. Banner KH, Page CP. Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma. Eur Respir J 1995; 8: 996-1000.
22. Persson CGA, Erjefält JS. Eosinophil lysis and free granules: an in vivo paradigm for cell activation and drug development. Trends Pharmacol Sci 1997; 18: 117-23.
23. Dent G, Rabe KF. Effects of theophylline and non-selective xantine derivatives on PDE isoenzymes and cellular function. In: Schudt C, Dent G and Rabe KF, eds. Phosphodiesterase Inhibitors. London: Academic Press, 1996; 41-64.
24. Ghio R, Scordamaglia A, D'Elia P et al. Inhibition of the colony-forming capacity of human T-lymphocytes exerted by theophylline. Int J Immunopharmac 1988; 10: 299-302.
25. Scordamaglia A, Ciprandi G, Ruffoni S et al. Theophylline and the immune response: in vitro and in vivo effects. Clin Immunol Immunopathol 1988; 48: 238-46.
26. Zocchi MR, Pardi R, Gromo G et al. Theophylline induced non specific suppressor activity in human peripheral blood lymphocytes. J Immunopharmacol 1985; 7: 217-34.
27. Shohat B, Volovitz B, Varsano I. Induction of suppressor T cells in asthmatic children by theophylline treatment. Clin Allergy 1983; 13: 487-93.
28. Fink G, Mittelman M, Shohat B, Spitzer SA. Theophylline-induced alterations in cellular immunity in asthmatic patients. Clin Allergy 1987; 17: 313-6.
29. Prieur AM, Granger GA. The effect of agents which modulate levels of the cyclic nucleotides on human lymphotoxin secretion and activity in vitro. Transplantation 1975; 20: 331-7.
30. McLeish KR, Wellhausen SR, Dean WL. Biochemical basis of HLA-DR and CR3 modulation on human peripheral blood monocytes by lipopolysaccharide. Cell Immunol 1987; 108: 242-8.
31. Calhoun WJ, Stevens CA, Lambert SB. Modulation of superoxide production of alveolar macrophages and peripheral blood mononuclear cells by β-agonists and theophylline. J Lab Clin Med 1991: 117: 514-22.
32. Bailly S, Ferrua B, Fay M, Gougerot-Pocidalo MA. Differential regulation of IL 6, IL 1 A, IL 1 beta and TNF alpha production in LPS-stimulated human monocytes: role of cyclic AMP. Cytokine 1990; 2: 205-10.
33. Mascali JJ, Cvietusa P, Negri J, Borish L. Anti-inflammatory effects of theophylline: modulation of cytokine production. Ann Allergy Asthma Immunol 1996; 77: 34-8.
34. Stephens CG, Snyderman R. Cyclic nucleotides regulate the morphologic alterations required for chemotaxis in monocytes. J Immunol 1982; 128: 1192-7.
35. Dent G, Giembycz MA, Rabe KF, Wolf B, Barnes PJ, Magnussen H. Theophylline suppresses human alveolar macrophage respiratory burst through phosphodiesterase inhibition. Am J Respir Cell Mol Biol 1994; 10: 565-72.
36. Baker AJ, Fuller RW. Effect of cyclic adenosine monophosphate, 5′-(N-ethylcarboxamido)-adenosine and methylxanthines on the release of thromboxane and lysosomal enzymes from human alveolar macrophages and peripheral blood monocytes in vitro. Eur J Pharmacol 1992; 211: 157-61.
37. O'Neill SJ, Sitar DS, Klass DJ, Taraska VA, Kepron W, Mitenko PA. The pulmonary disposition of theophylline and its influence on human alveolar macrophage bactericidal function. Am Rev Respir Dis 1986; 134: 1225-8.
38. Schmeichel CJ, Thomas LL. Methylxanthine bronchodilators potentiate multiple human neutrophil functions, J Immunol 1987, 138: 1896-903.
39. Ohta K, Sawamoto S, Nakajima M et al. The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis. Clin Exp Allergy 1996; 26 (Suppl. 2): 10-5.
40. 4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Br J Pharmacol 1996; 118: 1727-35.
41. Condino-Neto A, Vilela MM, Cambiucci EC et al. Theophylline therapy inhibits neutrophil and mononuclear cell chemotaxis from chronic asthmatic children. Br J Clin Pharmacol 1991; 32: 557-61.
42. Sanjar S, Aoki S, Kristersson A, Smith D, Morley J. Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs. Br J Phamiacol 1990; 99: 679-86.
43. Banner KH, Page CP. Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs. Br J Pharmacol 1995; 114: 93-8.
44. Santing RE, Olymulder CG, Van der Molen K, Meurs H, Zaagsma J. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs. Eur J Pharmacol 1995; 275: 75-82,
45. Rabe KF, Dent G, Magnussen H. Theophylline in the treatment of bronchial asthma and chronic obstructive pulmonary disease. In: Leff AR, ed. Pulmonary and Critical Care Pharmacology and Therapeutics. New York: McGraw-Hill, 1996; 525-34.
46. Magnussen H, Reuss G, Jörres R. Theophylline has a dose-related effect on the airway response to inhaled histamine and methacholine in asthmatics. Am Rev Respir Dis 1987; 136: 1163-7.
47. Magnussen H, Reuss G, Jörres R. Methylxanthines inhibit exercise-induced bronchoconstriction at low serum theophylline concentration and in a dose-dependent fashion. J Allergy Clin Immunol 1988; 81: 531-7.
48. Pollock J, Kiechel F, Cooper D, Weinberger M. Relationship of serum theophylline concentration to inhibition of exercise-induced bronchospasm and comparison with cromolyn. Pediatrics 1977; 60: 840-6.
49. Pauwels R, van Renterghem D, van der Straeten M, Johannesson N, Persson CGA. The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. J Allergy Clin Immunol 1985; 76: 583-90.
50. Mapp C, Boschetto P, Dal Vecchio L et al. Protective effect of antiasthma drugs on late asthmatic reactions and increased airway responsiveness induced by toluene diisocynanate in sensitized subjects. Am Rev Respir Dis 1987; 136: 1403-7.
51. Rabe KF, Dent G. Drugs that inhibit phosphodiesterase: chemistry, efficacy, and toxicity. In: Leff AR, ed. Pulmonary and Critical Care Pharmacology and Therapeutics. New York: McGraw-Hill, 1996; 509-15.